Production of recombinant collagen: state of the art and challenges

  title={Production of recombinant collagen: state of the art and challenges},
  author={Tianyi Wang and J Lew and J. Premkumar and Chueh Loo Poh and May W Naing},
Collagen, which is often used in healthcare materials and biomedical research, is largely extracted from animal sources. Recombinant human collagen has the potential to be a promising alternative to animal collagen which has many shortcomings, including immunogenicity and lack of biocompatibility. Currently, recombinant human collagen has been expressed in both eukaryotic and prokaryotic hosts with varying degrees of success. One issue with recombinant collagen across all hosts is the inability… 

Sources of Collagen for Biomaterials in Skin Wound Healing

Recombinant collagen is a potential solution to the aforementioned issues, although production of correctly post-translationally modified recombinant human collagen has not yet been performed at industrial scale.

An Overview of the Use of Equine Collagen as Emerging Material for Biomedical Applications

This work aims to overview the properties of Equine collagen making it particularly appealing in medicine, cosmetics and pharmaceuticals, as well as its main biomedical applications and the currently approved equine collagen-based medical devices, focusing on experimental studies and clinical trials of the last 15 years.

A regulatory perspective on recombinant collagen-based medical devices

Natural-Based Biomaterial for Skin Wound Healing (Gelatin vs. Collagen): Expert Review

This review compared Col and gelatin in terms of their structures, sources of derivatives, physicochemical properties, results of in vitro and in vivo studies, their roles in wounds healing and the current challenges in wound healing.

From small to large-scale: a review of recombinant spider silk and collagen bioproduction

Main challenges for successful large-scale implementation—such as recombinant silk durability and the continuous need to improve process economics—and main opportunities such as demand growth of recombinant spider silk and human collagen are outlined.

Additive Biomanufacturing with Collagen Inks

Additive biomanufacturing may help to overcome regulatory hurdles commercializing collagen biomaterials and fulfill its potential for biomedicine.

Marine collagen and its derivatives: Versatile and sustainable bio-resources for healthcare.

Method for purification of collagen: A systematic review

Four types of purification methods that commonly used to purify various types of collagen from mammals, marine, bacteria, and recombinant collagen are found.

Mimicking the Hierarchical Organization of Natural Collagen: Toward the Development of Ideal Scaffolding Material for Tissue Regeneration

The aim of this review is to highlight the most recent findings on the development of collagen-based scaffolds with optimized properties for tissue engineering.

Nature-Based Biomaterials and Their Application in Biomedicine

Current therapeutic applications of biomaterials derived from and inspired by natural proteins and polysaccharides are outlined and their promise across diverse biomedical fields are highlighted.



Shining light on collagen: expressing collagen in plants.

Progress toward plant production of collagens, the ability to self-assemble these recombinant proteins into higher-order structures, and the utility of these materials in various medical applications suggest an important path forward for the field.

Liquid crystalline human recombinant collagen: the challenge and the opportunity.

Recombinant human collagen produced in transgenic tobacco plants has the capacity of forming highly concentrated liquid crystalline dope that can be aligned by application of shear force, opening new possibilities toward obtaining scaffolds that may be able to provide the necessary mechanical support, while closely mimicking the molecular signals and mechanical cues displayed to natural cell milieu.

Recombinant expression systems for the production of collagen.

The application of various expression systems to procollagen production is outlined and the use of the mammary gland is detailed as a suitable bioreactor for the synthesis of significant amounts of novel procollagens from cDNA constructs.

Expression of recombinant human type I-III collagens in the yeast pichia pastoris.

Methods for producing the three major fibril-forming human collagens, types I, II and III, in the methylotrophic yeast Pichia pastoris are developed, based on co-expression of procollagen polypeptide chains with the alpha- and beta-subunits of prolyl 4-hydroxylase.

Production of bioactive, post-translationally modified, heterotrimeric, human recombinant type-I collagen in transgenic tobacco.

Collagen's biocompatibility, biodegradability and low immunogenicity render it advantageous for extensive application in pharmaceutical or biotechnological disciplines. However, typical collagen

Ultrarapid purification of collagen type I for tissue engineering applications.

A 3-h method to isolate COL1 from rabbit, lamb, and human skin in sufficient quantities by using a rapid agitation technique and incorporating centrifugal filtration units into a traditional isolation procedure increases the feasibility of autologous COL1 use in humans as well as overall safety for clinical patients.

Collagen interactions: Drug design and delivery.

Characterization of Recombinant Human Type IX Collagen

The results suggest that the most favored molecular species is an α1(ix)α2(IX)α3(IX), but the chains are also able to form disulfide-bonded heterotrimers of α1-IX and α3-IX chains and (α1(IX))3, (α2-IX)3, and ( α3(ix))3 homotriming.